With the increased demand for targeted therapies, pharmaceutical companies and other healthcare organizations are searching for novel biomarkers that will improve treatment outcomes. Beyond our current menu of tests, you may collaborate with our scientists to develop and validate assays unique to your trial and company needs.
The custom assay design and validation process includes PGXL meeting with your team to thoroughly understand what your goals are, conducting an initial bioinformatics review, and, of course, the assay design and validation. The process typically takes 6-8 weeks. Pricing depends on the genes of interest and the complexity of the project.